Cullen Frost Bankers Inc. Has $88,000 Holdings in Doximity, Inc. $DOCS

Cullen Frost Bankers Inc. lifted its position in shares of Doximity, Inc. (NASDAQ:DOCS) by 29.7% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,427 shares of the company’s stock after buying an additional 327 shares during the quarter. Cullen Frost Bankers Inc.’s holdings in Doximity were worth $88,000 at the end of the most recent reporting period.

Several other large investors also recently modified their holdings of DOCS. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its position in shares of Doximity by 130.4% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 1,966,801 shares of the company’s stock worth $114,133,000 after buying an additional 1,113,076 shares during the period. Vanguard Group Inc. increased its position in shares of Doximity by 8.8% during the first quarter. Vanguard Group Inc. now owns 12,194,492 shares of the company’s stock worth $707,646,000 after buying an additional 990,923 shares during the period. Invesco Ltd. increased its position in shares of Doximity by 54.8% during the first quarter. Invesco Ltd. now owns 1,969,326 shares of the company’s stock worth $114,280,000 after buying an additional 696,923 shares during the period. William Blair Investment Management LLC increased its position in shares of Doximity by 13.8% during the second quarter. William Blair Investment Management LLC now owns 5,219,394 shares of the company’s stock worth $320,158,000 after buying an additional 634,927 shares during the period. Finally, Nuveen LLC acquired a new stake in Doximity in the first quarter worth $34,056,000. 87.19% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

DOCS has been the subject of a number of research reports. Evercore ISI raised their price target on shares of Doximity from $75.00 to $81.00 and gave the stock an “outperform” rating in a report on Wednesday, October 8th. Zacks Research cut shares of Doximity from a “strong-buy” rating to a “hold” rating in a report on Wednesday, August 20th. Truist Financial raised their price target on shares of Doximity from $52.00 to $61.00 and gave the stock a “hold” rating in a report on Thursday, July 17th. Raymond James Financial set a $75.00 price target on shares of Doximity in a report on Wednesday, September 10th. Finally, Canaccord Genuity Group raised their price target on shares of Doximity from $59.00 to $67.00 and gave the stock a “hold” rating in a report on Thursday, September 18th. One investment analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating, nine have assigned a Hold rating and two have given a Sell rating to the company’s stock. According to data from MarketBeat.com, Doximity presently has a consensus rating of “Hold” and an average target price of $69.37.

Doximity Stock Performance

Doximity stock opened at $66.93 on Friday. Doximity, Inc. has a fifty-two week low of $40.87 and a fifty-two week high of $85.21. The stock has a market cap of $12.54 billion, a PE ratio of 66.93, a price-to-earnings-growth ratio of 4.10 and a beta of 1.38. The firm’s 50-day simple moving average is $69.60 and its 200 day simple moving average is $61.81.

Doximity (NASDAQ:DOCS) last released its quarterly earnings results on Thursday, August 7th. The company reported $0.36 earnings per share for the quarter, topping the consensus estimate of $0.31 by $0.05. Doximity had a net margin of 36.60% and a return on equity of 21.75%. During the same quarter in the previous year, the firm earned $0.28 EPS. The company’s quarterly revenue was up 15.2% compared to the same quarter last year. Doximity has set its FY 2026 guidance at EPS. Q2 2026 guidance at EPS. As a group, analysts predict that Doximity, Inc. will post 0.99 EPS for the current fiscal year.

Insider Buying and Selling

In related news, Director Kira Scherer Wampler sold 2,000 shares of the business’s stock in a transaction dated Friday, August 1st. The shares were sold at an average price of $57.09, for a total transaction of $114,180.00. Following the transaction, the director directly owned 16,618 shares in the company, valued at approximately $948,721.62. The trade was a 10.74% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Timothy S. Cabral sold 20,000 shares of the business’s stock in a transaction dated Wednesday, September 24th. The stock was sold at an average price of $75.00, for a total transaction of $1,500,000.00. Following the transaction, the director owned 3,221 shares in the company, valued at approximately $241,575. This trade represents a 86.13% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 37,000 shares of company stock worth $2,635,880. 31.30% of the stock is owned by insiders.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.